Analysis of potential predictive factors of clinical benefit in patients (pts) with metastatic colorectal cancer (MCRC) treated with single-agent cetuximab as first-line treatment

被引：0
|
作者：
Gravalos, C.
Sastre, J.
Aranda, E.
Massuti, B.
Vega-Villegas, M. E.
Gomez, A.
Varella-Garcia, M.
Jimeno, A.
Diaz-Rubio, E.
Hidalgo, M.
机构：
[1] Hosp 12 Octubre, Madrid, Spain
[2] Hosp Clin San Carlos, Madrid, Spain
[3] Hosp Reina Sofia, Cordoba, Spain
[4] Hosp Gen Univ Alicante, Alicante, Spain
[5] Hosp Univ Marques de Valdecilla, Santander, Spain
[6] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Hosp Monteprincipe, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4120
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic Factors in Japanese Patients with Advanced Pancreatic Cancer Treated with Single-agent Gemcitabine as First-line Therapy
    Tanaka, Tsutomu
    Ikeda, Masafumi
    Okusaka, Takuji
    Ueno, Hideki
    Morizane, Chigusa
    Hagihara, Atsushi
    Iwasa, Satoru
    Kojima, Yasushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (11) : 755 - 761
  • [42] The role of the KRAS G13D mutation in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy plus cetuximab
    Tejpar, S.
    Bokemeyer, C.
    Celik, I.
    Schlichting, M.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [43] Cetuximab plus FOLFIRI first line in patients (pts) with metastatic colorectal cancer (mCRC): A quality-of-life (QoL) analysis of the CRYSTAL trial
    Folprecht, G.
    Nowacki, M.
    Lang, I.
    Cascinu, S.
    Shchepotin, I.
    Maurel, J.
    Rougier, P.
    Cunningham, D.
    Zubel, A.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Prognostic factors of patients (pts) with salvage-line metastatic colorectal cancer (mCRC)
    Bando, Hideaki
    Oki, Eiji
    Takeda, Yuriko
    Misumi, Toshihiro
    Suzuki, Motoko
    Wakabayashi, Masashi
    Yamazaki, Kentaro
    Grothey, Axel
    Mayer, Robert J.
    Li, Jin
    Andre, Thierry
    Shi, Qian
    De Gramont, Aimery
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 115 - 115
  • [45] Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer
    Sun, Der Sheng
    Jeon, Eun Kyoung
    Won, Hye Sung
    Park, Ji Chan
    Shim, Byoung Young
    Park, Suk Young
    Hong, Young Seon
    Kim, Hoon Kyo
    Ko, Yoon Ho
    GASTRIC CANCER, 2015, 18 (03) : 644 - 652
  • [46] Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer
    Der Sheng Sun
    Eun Kyoung Jeon
    Hye Sung Won
    Ji Chan Park
    Byoung Young Shim
    Suk Young Park
    Young Seon Hong
    Hoon Kyo Kim
    Yoon Ho Ko
    Gastric Cancer, 2015, 18 : 644 - 652
  • [47] SINGLE INSTITUTION RESULTS OF FIRST-LINE TREATMENT WITH BEVACIZUMAB PLUS CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (MCRC)
    Barkmanova, Jaroslava
    Petruzelka, Lubos
    Sedlackova, Eva
    Vocka, Michal
    Hejduk, Karel
    Bortlicek, Zbynek
    ANNALS OF ONCOLOGY, 2014, 25
  • [48] CETUXIMAB IN COMBINATION WITH XELIRI OR XELOX IN FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Boc, Marko
    Mesti, Tanja
    Moltara, Maja Ebert
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [49] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab
    Tonini, Giuseppe
    Calvieri, Alice
    Vincenzi, Bruno
    Santini, Daniele
    ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82
  • [50] KRAS MUTATIONS AND OUTCOME IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CETUXIMAB
    Tejpar, Sabine
    Bokemeyer, Carsten
    Celik, Ilhan
    Schlichting, Michael
    Heeger, Steffen
    Van Cutsem, Eric
    ANNALS OF ONCOLOGY, 2011, 22 : v16 - v17
12345